Durect Corp financial data

Symbol
DRRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
10240 Bubb Road, Cupertino, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 113 % -26.8%
Quick Ratio 8.7 % +28.7%
Return On Equity -149 % +17%
Return On Assets -38.1 % +37.9%
Operating Margin -296 % -54.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31M shares +12.5%
Common Stock, Shares, Outstanding 30.3M shares +33.1%
Entity Public Float 120M USD +11.5%
Common Stock, Value, Issued 23K USD 0%
Weighted Average Number of Shares Outstanding, Basic 31M shares +26.6%
Weighted Average Number of Shares Outstanding, Diluted 31M shares +26.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 8.41M USD -53.6%
Research and Development Expense 19.2M USD -47.3%
Costs and Expenses 33.3M USD -38.4%
Operating Income (Loss) -24.9M USD +28.2%
Nonoperating Income (Expense) 9.13M USD +73.8%
Net Income (Loss) Attributable to Parent -15.8M USD +56.2%
Earnings Per Share, Basic -0.46 USD/shares +69.7%
Earnings Per Share, Diluted -0.59 USD/shares +61.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15.6M USD -50.7%
Accounts Receivable, after Allowance for Credit Loss, Current 1.01M USD -22.4%
Inventory, Net 2.47M USD +9.37%
Assets, Current 20M USD -50.5%
Property, Plant and Equipment, Net 67K USD -55%
Operating Lease, Right-of-Use Asset 3.39M USD +65.9%
Goodwill 6.17M USD 0%
Other Assets, Noncurrent 128K USD +2033%
Assets 29.9M USD -38.6%
Accounts Payable, Current 394K USD -59.8%
Accrued Liabilities, Current 4.67M USD -40%
Contract with Customer, Liability, Current 178K USD
Liabilities, Current 21.9M USD -47.1%
Contract with Customer, Liability, Noncurrent 812K USD 0%
Operating Lease, Liability, Noncurrent 2.22M USD +176%
Other Liabilities, Noncurrent 669K USD -27.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7K USD -16.7%
Retained Earnings (Accumulated Deficit) -600M USD -2.7%
Stockholders' Equity Attributable to Parent 5.04M USD -8.42%
Liabilities and Equity 29.9M USD -38.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.77M USD +27%
Net Cash Provided by (Used in) Financing Activities -1.5M USD -115%
Net Cash Provided by (Used in) Investing Activities -887K USD +82%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 30.3M shares +33.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 15.8M USD -50.5%
Deferred Tax Assets, Valuation Allowance 123M USD +4.89%
Deferred Tax Assets, Gross 124M USD +5.37%
Operating Lease, Liability 4.08M USD +95.2%
Payments to Acquire Property, Plant, and Equipment 33K USD +1000%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.8M USD +56.2%
Lessee, Operating Lease, Liability, to be Paid 4.19M USD +66.8%
Property, Plant and Equipment, Gross 15M USD -22.3%
Operating Lease, Liability, Current 1.3M USD -1.89%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.44M USD +477%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.4M USD +170%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 903K USD +490%
Lessee, Operating Lease, Liability, to be Paid, Year Three 432K USD +67.4%
Deferred Tax Assets, Operating Loss Carryforwards 83.8M USD +0.59%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 13.6M USD +3.83%
Lessee, Operating Lease, Liability, to be Paid, Year Four 227K USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 51K USD +15.9%
Share-based Payment Arrangement, Expense 2.22M USD -8.34%
Interest Expense 2.15M USD -0.78%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%